2025 House Bill 4072 / 2026 Public Act 41

Health: pharmaceuticals; allow patients to take unused portion of eye drops or eye ointments after certain procedures for continued patient care; provide for.

An act to amend 1978 PA 368, entitled “An act to protect and promote the public health; to codify, revise, consolidate, classify, and add to the laws relating to public health; to provide for the prevention and control of diseases and disabilities; to provide for the classification, administration, regulation, financing, and maintenance of personal, environmental, and other health services and activities; to create or continue, and prescribe the powers and duties of, departments, boards, commissions, councils, committees, task forces, and other agencies; to prescribe the powers and duties of governmental entities and officials; to regulate occupations, facilities, and agencies affecting the public health; to regulate health maintenance organizations and certain third party administrators and insurers; to provide for the imposition of a regulatory fee; to provide for the levy of taxes against certain health facilities or agencies; to promote the efficient and economical delivery of health care services, to provide for the appropriate utilization of health care facilities and services, and to provide for the closure of hospitals or consolidation of hospitals or services; to provide for the collection and use of data and information; to provide for the transfer of property; to provide certain immunity from liability; to regulate and prohibit the sale and offering for sale of drug paraphernalia under certain circumstances; to provide for the implementation of federal law; to provide for penalties and remedies; to provide for sanctions for violations of this act and local ordinances; to provide for an appropriation and supplements; to repeal certain acts and parts of acts; to repeal certain parts of this act; and to repeal certain parts of this act on specific dates,” (MCL 333.1101 to 333.25211) by adding sections 17773, 20817, and 21539.

AI Analysis – Experimental

The legislation mandates that unused portions of specific ophthalmic drugs must be offered to patients upon discharge from hospitals or surgical facilities if needed for continued treatment, with compliance required from these facilities.

Introduced in the House

Feb. 12, 2025

Introduced by Rep. Samantha Steckloff (D-19) and 23 co-sponsors

Co-sponsored by Reps. Julie Rogers (D-41), Donavan McKinney (D-11), Cynthia Neeley (D-70), Carol Glanville (D-84), Carrie Rheingans (D-47), Regina Weiss (D-5), Laurie Pohutsky (D-17), Natalie Price (D-6), Phil Skaggs (D-80), Jason Morgan (D-23), Morgan Foreman (D-33), Sharon MacDonell (D-56), Stephanie Young (D-16), Jimmie Wilson (D-32), Emily Dievendorf (D-77), Julie Brixie (D-73), Erin Byrnes (D-15), Denise Mentzer (D-61), Gina Johnsen (R-78), Mike Hoadley (R-99), Jay DeBoyer (R-63), Kelly Breen (D-21) and Stephen Wooden (D-81)

Referred to the Committee on Health Policy

April 16, 2025

Reported without amendment

May 7, 2025

Passed in the House 109 to 0 (details)

Motion to give immediate effect by Rep. Bryan Posthumus (R-90)

The motion prevailed by voice vote

Received in the Senate

May 13, 2025

Referred to the Committee on Health Policy

March 4, 2026

Reported without amendment

March 5, 2026

Referred to the Committee of the Whole

July 1, 2026

Reported without amendment

July 2, 2026

Passed in the Senate 37 to 0 (details)

Signed by Gov. Gretchen Whitmer

July 22, 2026